GLP-1 Medications: What They Do, Who They Help, and the 2026 Evidence
GLP-1 receptor agonists treat diabetes, obesity, and cardiovascular risk. We break down how semaglutide and tirzepatide work, who benefits, what they cost, and what the 2026 evidence shows about muscle loss.